A recent study published in the journal Nature Medicine has shed new light on the role of genetics in Alzheimer’s disease. The study suggests that Alzheimer’s may be inherited more frequently than previously believed, with a specific gene, APOE4, playing a key role in the development of the disease.
Researchers propose that Alzheimer’s caused by the APOE4 gene should be considered an inherited form of the disease, rather than just a risk factor. In fact, people who have two copies of the APOE4 gene have a nearly certain diagnosis of Alzheimer’s by age 82.
The study compared thousands of brains and found that APOE4 leads to biological changes associated with Alzheimer’s, even if cognitive symptoms are not yet present. This suggests that APOE4 may be classified as a genetic form of the disease, affecting roughly 15% of Alzheimer’s cases.
While genetic testing for APOE4 status is not currently recommended, the study’s findings may lead to a shift in personalized treatment for Alzheimer’s in the future. Specifically, individuals with two copies of the APOE4 gene may benefit from earlier treatment and different medications to prevent the progression of symptoms.
The research highlights the importance of understanding the genetic factors that contribute to Alzheimer’s disease and may pave the way for more targeted and effective treatments in the future. As scientists continue to uncover the complexities of Alzheimer’s, further advancements in personalized medicine may offer hope for those affected by this devastating disease.
“Infuriatingly humble tv expert. Friendly student. Travel fanatic. Bacon fan. Unable to type with boxing gloves on.”